Nuveen
VXRT

Nuveen’s Vaxart VXRT Stock Holding History

Nuveen’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,219,532
Closed -$1.68M – 3301
2023
Q1 		$1.68M Buy
2,219,532
+1,210,794
+120% +$1.12M ﹤0.01% 2407
2022
Q4 		$970K Buy
1,008,738
+495,441
+97% +$700K ﹤0.01% 2693
2022
Q3 		$1.12M Sell
513,297
-4,845
-0.9% -$16.7K ﹤0.01% 2699
2022
Q2 		$1.81M Buy
518,142
+152,663
+42% +$570K ﹤0.01% 2482
2022
Q1 		$1.83M Buy
365,479
+4,475
+1% +$22.7K ﹤0.01% 2545
2021
Q4 		$2.19M Sell
361,004
-28,608
-7% -$195K ﹤0.01% 2525
2021
Q3 		$3.28M Sell
389,612
-33,427
-8% -$275K ﹤0.01% 2437
2021
Q2 		$3.17M Buy
423,039
+222,868
+111% +$1.56M ﹤0.01% 2489
2021
Q1 		$1.21M Buy
200,171
+3,815
+2% +$29.3K ﹤0.01% 2829
2020
Q4 		$1.12M Sell
196,356
-4,230
-2% -$26.9K ﹤0.01% 2762
2020
Q3 		$1.33M Buy
200,586
+3,268
+2% +$29.1K ﹤0.01% 2560
2020
Q2 		$1.75M Buy
+197,318
New +$567K ﹤0.01% 2399

Other funds holding VXRT

CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $26.8B AUM 90.85% 1-Year Est. Return

Nuveen's VXRT Position: Q2 2023 in Review

Nuveen sold out of Vaxart (VXRT) in Q2 2023, closing a stake of 2,219,532 shares — an estimated $1.68M sold.

Nuveen first reported a position in VXRT in Q2 2020 and held it in 12 quarters. The position peaked at $3.28M in Q3 2021. 111 funds tracked by Wall St. Rank hold VXRT as of Q2 2023.

  • Nuveen reported no remaining Vaxart position as of Q2 2023 after selling out during the quarter.
  • Nuveen sold 2,219,532 Vaxart shares in Q2 2023, an estimated $1.68M.
  • Nuveen first reported a position in Vaxart in Q2 2020 and held it in 12 quarters.
  • Nuveen's Vaxart position peaked at $3.28M in Q3 2021.
  • 111 funds tracked by Wall St. Rank held Vaxart as of Q2 2023.

Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.